相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement*
Lorenzo M. Donini et al.
CLINICAL NUTRITION (2022)
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly
Stefano Frara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence – Authors' reply
Maria Fleseriu et al.
Lancet Diabetes & Endocrinology (2022)
Effects of Medical Treatment of Prostate Cancer on Bone Health
Anna Maria Formenti et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Assessment of non-traumatic vertebral fractures in Cushing's syndrome patients
T. Apaydin et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Osteopathy in mild adrenal Cushing's syndrome and Cushing disease
Stefano Frara et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?
John P. Bilezikian et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
Consensus on diagnosis and management of Cushing's disease: a guideline update
Maria Fleseriu et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes
Luigi di Filippo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs
Sabrina Chiloiro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Pojchong Chotiyarnwong et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Pituitary Tumors Centers of Excellence
Stefano Frara et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)
Controversies in Vitamin D: A Statement From the Third International Conference
Andrea Giustina et al.
JBMR PLUS (2020)
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy
Rebecca Pedersini et al.
JAMA NETWORK OPEN (2019)
Pituitary Diseases and Bone
Gherardo Mazziotti et al.
ENDOCRINE REVIEWS (2018)
Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects
G. Mazziotti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Growth hormone deficiency in treated acromegaly and active Cushing's syndrome
Anna Maria Formenti et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Endogenous subclinical hypercortisolism and bone: a clinical review
I. Chiodini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines
Gherardo Mazziotti et al.
ENDOCRINE (2016)
Bone density and microarchitecture in endogenous hypercortisolism
Camila V. dos Santos et al.
CLINICAL ENDOCRINOLOGY (2015)
The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome
Zhanna E. Belaya et al.
ARCHIVES OF OSTEOPOROSIS (2015)
Diagnosis and complications of Cushing's disease: gender-related differences
Marialuisa Zilio et al.
CLINICAL ENDOCRINOLOGY (2014)
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
A. Scillitani et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Glucocorticoids and the regulation of growth hormone secretion
Gherardo Mazziotti et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Spontaneous recovery of bone mass after cure of endogenous hypercortisolism
Maria Elena Randazzo et al.
PITUITARY (2012)
New understanding and treatments for osteoporosis
G. Mazziotti et al.
ENDOCRINE (2012)
Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial
Chi Chiu Mok et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006
Amy L. Skversky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Treatment of Cushing disease: overview and recent findings
Tatiana Mancini et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2010)
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
E. Canalis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study
Alberto Angeli et al.
BONE (2006)
Bone demineralization and vertebral fractures in endogenous cortisol excess:: Role of disease etiology and gonadal status
L Tauchmanová et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects
S Bonadonna et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: The effects of subclinical hypercortisolism and gonadal status
I Chiodini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Perspectives on glucocorticoid-induced osteoporosis
E Canalis et al.
BONE (2004)
Increased risk of osteoporotic fractures in patients with Cushing's syndrome
P Vestergaard et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
分享论文
